期刊文献+

左乙拉西坦对自发性癫痫大鼠大发作和小发作的作用(英文) 被引量:6

Effects of levetiracetam on absence-like seizures and tonic convulsion in spontaneously epileptic rats
暂未订购
导出
摘要 目的 鉴于左乙拉西坦在各种啮齿类动物上的抗癫痫作用不同 ,未见报告其在自发性癫痫大鼠上的作用 ,故研究之。方法 在大脑海马和皮质部位安置电极 ,观察腹腔注射单剂量左乙拉西坦对自发性癫痫大鼠脑电图的影响。结果 给左乙拉西坦(40 ,80和 16 0mg·kg- 1,ip)后 135~ 16 5min ,癫痫小发作的总持续时间分别下降到给药前水平的 (87±15 ) % ,(34± 7) %和 (39± 19) %。大发作的总持续时间下降到 (81± 2 8) % ,(6 5± 11) %和 (5 2± 7) %。大发作的出现频率下降到 (71± 2 9) % ,(5 4± 12 ) %和 (32± 15 ) %。 AIM In view of the difference of the effects of levetiracetam (Lev) in different rodent models and there is no report on its effects in spontaneously epileptic rats (SER), the effects were studied. METHODS Electrocorticogram and depth electroencephalographic activity in hippocampus of SER were recorded with implanted electrodes after acute intraperitoneally administration of Lev. RESULTS The total duration of absence-like seizures was significantly reduced from 100% to (87±15)%, (34±7)% and (39±19)% by single dose Lev (40, 80 and 160 mg·kg -1, ip), respectively, at 135-165 min after administration. The frequency of tonic convulsion was reduced from 100% to (71±29)%, (54±12)% and (32±15)%. The total duration of tonic convulsion was also reduced to (81±28)%, (65±11)% and (52±7)%, respectively. CONCLUSION Lev is effective for treatment of absence-like seizures and tonic convulsion on SER.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2002年第4期241-245,共5页 Chinese Journal of Pharmacology and Toxicology
关键词 左乙拉西坦 大鼠 自发性癫痫 脑电图 海马 levetiracetam epilepsy rats, spontaneously epileptic hippocampus electroencephalography
  • 相关文献

参考文献14

  • 1Shorvon SD, Lowenthal A, Janz D,Bielen E, Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial oflevetiracetam as add-on therapy in patients with refractory partial seizures[J].Epilepsia, 2000, 41(9): 1179-1186.
  • 2Sohn YH, Kaelin-Lang A, Jung HY, Hallett M. Effect of levetiracetam on humancorticospinal excitability[J]. Neurology, 2001, 57(5):858-863.
  • 3Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetamfor partial seizures: results of a double-blind, randomized clinical trial[J]. Neurology,2000, 55(2):236-242.
  • 4Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novelanticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobeepilepsy[J]. J Pharmacol Exp Ther, 1998, 284(2):474-479.
  • 5Gower AJ, Hirsch E, Boehrer A, Noyer M, Marescaux C. Effects of levetiracetam, anovel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy[J].Epilepsy Res, 1995, 22(3):207-213.
  • 6Klitgaard H, Matagne A, Gobert J, Wulfert E. Evidence for a unique profile oflevetiracetam, in rodent models of seizures and epilepsy[J]. Eur J Pharmacol, 1998, 353(2-3):191-206.
  • 7Yamada J, Serikawa T, Ishiko J, Inui T, Takada H, Kawai Y, et al. Rats withcongenital tremor and curled whiskers and hair[J]. Jikken Dobutsu, 1985, 34(2): 183-188.
  • 8Rhem S, Mehraein P, Anzil AP, Deerberg F. A new rat mutant with defective overhairsand spongy degeneration of the central nervous system: clinical and pathologic studies[J].Lab Anim Sci, 1982, 32(1):70-73.
  • 9Sasa M, Zhu AH, Amano T, Ishihara K, Kohno S, Ying JQ, et al. Effects of clobazamon epileptic seizures in spontaneously epileptic rats (SER)[J]. Jpn Pharmacol Ther, 2000,28(4):259-265.
  • 10Paxinos G, Watson C. The rat brain in stereotaxic coordinates[M]. 2nd ed. Sydney:Academic Press, 1986. Fig 32-Fig 35.

同被引文献37

  • 1邹丽萍,伍云.抗癫痫新药儿科应用研究进展[J].世界临床药物,2004,25(6):330-333. 被引量:6
  • 2田国红,赵忠新.左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J].中国新药与临床杂志,2006,25(10):782-786. 被引量:46
  • 3林庆.实用小儿癫痫病学[M]北京:北京科学技术出版社,2004.
  • 4Lynch BA,Lambeng N,Nocka K. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam[J].Proceedings of the National Academy of Sciences(USA),2004,(26):9861-9866.
  • 5Striano P,Goppola A,Pezzela M. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy[J].Neurology,2007,(03):250-254.
  • 6Grosso S,Cordellid M,Franaoni E. Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy[J].Seizure-European Journal of Epilepsy,2007,(04):345-350.
  • 7Grosso S,Franzoni E,Coppola G. Efficacy and safety of levetiracetam:an add-on trial in children with refactoryepilepsy[J].Seizure-European Journal of Epilepsy,2005,(04):248-253.
  • 8Mikati MA,ElBanna D,Sinno D. Response of infantile spasms to levetiracetam[J].Neurology,2008,(07):574-575.
  • 9Ilo E,Leppik C. The pace of levetiracetam in the treatment of epilepsy[J].Epilepsia,2001,(z4):44-45.
  • 10Zona C,Niespodziany I,Marchetti C. Levetiracetam does not modulate neuronal voltage-gated Na and T-type Ca currents[J].Seizure-European Journal of Epilepsy,2001,(04):279-286.

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部